Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer
A Guihot, AG Marcelin, MA Massiani… - Annals of …, 2018 - annalsofoncology.org
A 51-year-old man, smoker, HIV-infected since 1995, diagnosed with stage IIIa epidermal
growth factor receptor-/BRAF-/Kras-/Programmed Cell Death Ligand-1-non-small-cell lung
cancer in May 2015 was treated with lobectomy and adjuvant chemotherapy (cisplatin and
pemetrexed). Relapse occurred< 6months after the end of chemotherapy and nivolumab
was introduced as a second line in December 2016, upon the CANCERVIH working group
recommandations. CANCERVIH is a national French multidisciplinary network dedicated to …
growth factor receptor-/BRAF-/Kras-/Programmed Cell Death Ligand-1-non-small-cell lung
cancer in May 2015 was treated with lobectomy and adjuvant chemotherapy (cisplatin and
pemetrexed). Relapse occurred< 6months after the end of chemotherapy and nivolumab
was introduced as a second line in December 2016, upon the CANCERVIH working group
recommandations. CANCERVIH is a national French multidisciplinary network dedicated to …
